Protein kinase C inhibitors as novel anticancer drugs

Author： Jirousek Michael R Goekjian Peter G

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.12, 2001-12, pp. : 2117-2140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspectives of Protein Kinase C (PKC) Inhibitors as Anti-Cancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-04 ,pp. : 498-509

Bentham Science Publishers

Access to resources Recommend Favorite

Dawn of Aurora kinase inhibitors as anticancer drugs

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 9, 2004-09 ,pp. : 1199-1201

Informa Healthcare

Access to resources Recommend Favorite

Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 291-302

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4725-4746

Bentham Science Publishers

Access to resources Recommend Favorite

A Comparison of Physicochemical Property Profiles of Marketed Oral Drugs and Orally Bioavailable Anti-Cancer Protein Kinase Inhibitors in Clinical Development

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 14, 2007-07 ,pp. : 1408-1422

Bentham Science Publishers

Access to resources Recommend Favorite